GSE183606 rutaecarpine 1 v 0 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE183606_rutaecarpine_1_v_0_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE183606_rutaecarpine_1_v_0_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE183606_rutaecarpine_1_v_0_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE183606_rutaecarpine_1_v_0_human_up.

Results found

Linked to

 

Label

Description

 

Gene

A-kinase anchoring protein 17A

Gene

PAX8 antisense RNA 1

Gene

long intergenic non-protein coding RNA 662

Gene

CENPB DNA-binding domains containing 2, pseudogene

Gene

MIR3142 host gene

Gene

nicotinamide phosphoribosyltransferase pseudogene 1

Gene

uncharacterized LOC124901321

Gene

C2orf74 divergent transcript

Gene

long intergenic non-protein coding RNA 1547

Gene

KDM7A divergent transcript

  • Gene

    A-kinase anchoring protein 17A


  • Gene

    PAX8 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 662


  • Gene

    CENPB DNA-binding domains containing 2, pseudogene



  • Gene

    nicotinamide phosphoribosyltransferase pseudogene 1


  • Gene

    uncharacterized LOC124901321


  • Gene

    C2orf74 divergent transcript


  • Gene

    long intergenic non-protein coding RNA 1547


  • Gene

    KDM7A divergent transcript

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.